Position in RCUS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$28,340,970
+$2,263,852 QoQ
Shares Held
919,266
-23.9% QoQ
Ownership
0.722%
of shares outstanding
% of Portfolio
2.94%
of 13F equity value
Holder Rank
#23
of 228 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RCUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Parkman Healthcare Partners LLC holds $508,391,007 across 37 Biotechnology names. RCUS ranks #3 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MBX |
MBX Biosciences, Inc.
|
800,173 | $44,169,549 | |
| 2 | PTCT |
Ptc Therapeutics, Inc.
|
435,691 | $35,539,314 | |
| 3 | RCUS |
Arcus Biosciences, Inc.
This page
|
919,266 | $28,340,970 | |
| 4 | GPCR |
Structure Therapeutics Inc.
|
485,661 | $26,065,425 | |
| 5 | VRDN |
Viridian Therapeutics, Inc.\DE
|
1,377,576 | $25,306,071 | |
| 6 | AGIO |
Agios Pharmaceuticals, Inc.
|
669,046 | $24,828,297 | |
| 7 | INBX |
Inhibrx Biosciences, Inc.
|
256,950 | $24,346,012 | |
| 8 | XENE |
Xenon Pharmaceuticals Inc.
|
397,379 | $23,985,796 |
All Filings in RCUS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,340,970 | 919,266 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $26,077,118 | 1,207,274 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $23,081,785 | 968,602 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $8,876,448 | 652,680 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,880,825 | 599,610 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $9,542,687 | 1,215,629 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $18,966,718 | 1,273,789 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $15,683,778 | 1,025,754 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $6,328,598 | 415,535 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $4,907,289 | 259,920 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,730,382 | 247,664 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,681,706 | 205,109 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,438,195 | 120,049 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,878,482 | 102,987 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,808,672 | 87,460 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $3,607,307 | 137,894 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,338,562 | 171,214 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $5,280,650 | 167,321 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $4,738,996 | 117,099 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $8,251,532 | 236,637 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $6,772,652 | 246,637 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $8,869,966 | 315,882 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $6,016,437 | 231,758 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $4,028,551 | 235,038 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $3,958,400 | 160,000 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||